Stay updated on Radiolabeled SNDX-5613 in Acute Leukemia Clinical Trial
Sign up to get notified when there's something new on the Radiolabeled SNDX-5613 in Acute Leukemia Clinical Trial page.

Latest updates to the Radiolabeled SNDX-5613 in Acute Leukemia Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedRevision: v3.4.2 was added to the site footer, and the previous funding-status notice along with Revision: v3.4.1 were removed.SummaryDifference0.5%

- Check21 days agoChange DetectedA site-wide notice about government funding and a version update (v3.4.1) were added; the study details and data remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check28 days agoChange DetectedAdded a glossary toggle and updated QC metadata (Last Update Submitted that Met QC Criteria and Revision: v3.4.0). Removed the older QC heading, No FEAR Act data label, and the previous Revision value (v3.3.4).SummaryDifference0.2%

- Check42 days agoChange DetectedFooter revision updated to v3.3.4, replacing v3.3.3. This appears to be a minor site update that does not affect the study details.SummaryDifference0.1%

- Check64 days agoChange DetectedThe page now lists a Texas location (Houston, MD Anderson Cancer Center) under Locations. The HHS Vulnerability Disclosure link was removed and the page revision shows v3.3.3.SummaryDifference0.2%

- Check85 days agoChange DetectedA minor revision tag was updated from v3.3.1 to v3.3.2, which does not affect study content or page details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Radiolabeled SNDX-5613 in Acute Leukemia Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Radiolabeled SNDX-5613 in Acute Leukemia Clinical Trial page.